EYELID TUMOUR

EYELID TUMOUR was reported 76 times

These drug classes are most commonly taken by patients reporting EYELID TUMOUR:

# Drug Count
0 Kinase Inhibitor [EPC] 7
1 Corticosteroid [EPC] 5
2 Nonsteroidal Anti-inflammatory Drug [EPC] 5
3 Tumor Necrosis Factor Blocker [EPC] 5
4 Calcium Channel Blocker [EPC] 4
5 Dihydropyridine Calcium Channel Blocker [EPC] 4
6 Interleukin-4 Receptor alpha Antagonist [EPC] 3
7 Alkylating Drug [EPC] 2
8 Angiotensin 2 Receptor Blocker [EPC] 2
9 Benzodiazepine [EPC] 2
10 CD20-directed Cytolytic Antibody [EPC] 2
11 Calcium [EPC] 2
12 Insulin Analog [EPC] 2
13 Platelet Aggregation Inhibitor [EPC] 2
14 Proton Pump Inhibitor [EPC] 2
15 RANK Ligand Inhibitor [EPC] 2
16 Sulfonylurea [EPC] 2
17 Thiazide Diuretic [EPC] 2
18 Vitamin D [EPC] 2
19 mTOR Inhibitor Immunosuppressant [EPC] 2
20 Angiotensin Converting Enzyme Inhibitor [EPC] 1
21 Antirheumatic Agent [EPC] 1
22 Aromatase Inhibitor [EPC] 1
23 Atypical Antipsychotic [EPC] 1
24 BCL-2 Inhibitor [EPC] 1
25 CTLA-4-directed Blocking Antibody [EPC] 1
26 Calcineurin Inhibitor Immunosuppressant [EPC] 1
27 Central alpha-2 Adrenergic Agonist [EPC] 1
28 Folate Analog Metabolic Inhibitor [EPC] 1
29 HER2/neu Receptor Antagonist [EPC] 1
30 HMG-CoA Reductase Inhibitor [EPC] 1
31 Hedgehog Pathway Inhibitor [EPC] 1
32 Histamine-1 Receptor Antagonist [EPC] 1
33 Interleukin-6 Receptor Antagonist [EPC] 1
34 Microtubule Inhibitor [EPC] 1
35 Neonatal Fc Receptor Blocker [EPC] 1
36 Nucleoside Metabolic Inhibitor [EPC] 1
37 Parathyroid Hormone-Related Peptide Analog [EPC] 1
38 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
39 Prostaglandin Analog [EPC] 1
40 Pyrimidine Synthesis Inhibitor [EPC] 1
41 Reducing and Complexing Thiol [EPC] 1
42 Thalidomide Analog [EPC] 1
43 Thiazide-like Diuretic [EPC] 1
44 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
45 Vitamin B12 [EPC] 1
46 Vitamin C [EPC] 1
47 beta-Adrenergic Blocker [EPC] 1